Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0605
D

Failure to Document Non-Pharmacological Interventions and Rationale for Psychotropic Medication Use

Palm Desert, California Survey Completed on 06-06-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to ensure that two residents were free from unnecessary psychotropic medications by not documenting the use or evaluation of non-pharmacological interventions (NPI) prior to initiating these medications. For both residents, there was no evidence in the medical records that behavioral, environmental, or person-centered approaches were attempted or monitored before and during the administration of psychotropic drugs, including duloxetine, amitriptyline, citalopram, and temazepam. The care plans referenced the need for non-drug interventions, but there was no documentation that these were implemented or evaluated in practice. For one resident with major depressive disorder, orders for duloxetine and amitriptyline were initiated without any documented trial or assessment of NPI, and the care plan did not address non-pharmacological strategies for the ongoing use of these medications. Similarly, another resident with insomnia and depression was started on citalopram and temazepam without documentation of attempted or evaluated NPI, despite the care plan instructing staff to assess and modify environmental or behavioral factors before starting hypnotic therapy. In both cases, the Director of Nursing confirmed the absence of documentation regarding the implementation and monitoring of NPI alongside the continued use of psychotropic medications. Additionally, for the resident receiving temazepam as a PRN medication, there was no documented rationale from the prescriber for extending the PRN order beyond 14 days, as required by facility policy. The facility's own policy mandates that psychotropic medications should not be used without first attempting non-drug interventions and that PRN orders for such medications must be justified and time-limited unless a rationale is documented. These documentation failures were confirmed during interviews and record reviews with facility leadership.

An unhandled error has occurred. Reload 🗙